Delivery Order SPE2DB20D3103-SPE2DB25FM2A7

Award Date 1/6/25
Potential Completion Date 1/7/25
Potential Value $1.2K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $7,709.84, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,562,601,125 units of Cetirizine Hydrochloride 10 mg tablets, a generic pharmaceutical product used to treat allergies. The contract is a Delivery Order, with a Firm Fixed Price pricing type, and an ultimate completion date of October 26, 2023. It is not...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,048.75 firm fixed-price delivery order contract is for the supply of Cetirizine HCL 10 mg tablets. The contract is not designated as a set-aside and serves as a delivery order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,780.54 firm fixed-price delivery order is for the supply of 4,566,372,069 units of Cetirizine HCL 5 mg tablets. The contract has an ultimate completion date of November 8, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,197.91 firm-fixed-price delivery order is for the supply of 4,562,549,817 units of Cetirizine HCL 5 mg tablets. The contract has an ultimate completion date of October 23, 2023. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the...
This is a delivery order issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, valued at $1,172.53. The order is for 4,560,567,361 units of Cetirizine HCl 10 mg tablets, a generic antihistamine medication. The delivery order is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA, valued at $999,999,999 and running through November 2026. This...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $63,512.75, is for the delivery of 4,563,866,824 units of the drug Cetirizine HCL 5 mg tablets in 100-count bottles. The contract is a delivery order under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA, valued at $999,999,999 and running through...
This federal contract award is a delivery order (SPE2DB20D3101|SPE2DB24FRTJ5) issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,117.56 firm fixed price contract is for the delivery of 4,565,618,723 units of Cetirizine HCL 5 mg tablets, which are used to treat various medical conditions. The contract has an ultimate completion date of August 29, 2024 and was awarded on August 28, 2024. This...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,514.12 firm fixed-price delivery order is for the supply of cetirizine hydrochloride 10 mg tablets, a common antihistamine medication, to support federal healthcare programs. The award is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at...
This federal contract award, valued at $2,051.14, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract is for the delivery of 4,566,674,952 units of Cetirizine HCL 10 mg tablets, a pharmaceutical product used for various medical purposes. The contract has a completion date of December 11, 2024 and utilizes a firm fixed-price pricing structure. It is not designated as a set-aside contract. Amerisourcebergen Drug Corp is a major...
This federal contract award, valued at $1,782.40, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract provides for the delivery of 4,564,041 units of Cetirizine HCl 10 mg tablets, a common antihistamine medication, with a completion date of March 22, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999...
  • SPE2DB20D3103
    Indefinite Delivery Contract
  • SPE2DB20D3103-SPE2DB25FM2A7
    Delivery Order

This federal contract award, valued at $1,168.23, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,566,844 units of Cetirizine HCL 5 mg tablets, a generic antihistamine medication, with a completion date of January 7, 2025.

The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition.

Generated 4/7/25, 9:43 AM